09.09.26 -- Why Representation Is More Than A Diversity Checkbox

While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.

The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.

Comprehensive, validated laboratory testing paired with advanced instrumentation and seamless EDC integration helps streamline clinical trials without downtime or data gaps.

Investigators’ meetings are a great opportunity to clarify available services early, provide access to support teams, and surface your study's needs before they become barriers.

In this presentation, you’ll get recommendations to help you stay inspection-ready and learn about the importance of clear roles, audit trails, data integrity, and training.

Kemi Williams explains the distinction between diversity and representation, using the donanemab Alzheimer’s trial as an example of how underrepresentation can create real clinical and labeling consequences.

See how AI, real-world data, and agentic technologies are helping clinical teams improve patient selection, streamline operations, and speed trial outcomes.